No abstract available
MeSH terms
-
Administration, Oral
-
Aged
-
Alendronate / adverse effects*
-
Bone Density Conservation Agents / adverse effects*
-
Diphosphonates / adverse effects
-
Esophageal Neoplasms / chemically induced*
-
Esophageal Neoplasms / epidemiology
-
Esophageal Neoplasms / mortality
-
Europe / epidemiology
-
Female
-
Humans
-
Japan / epidemiology
-
Male
-
Risk Factors
-
United States / epidemiology
Substances
-
Bone Density Conservation Agents
-
Diphosphonates
-
Alendronate